110 related articles for article (PubMed ID: 1601359)
1. [Increased expression of growth factors following angioplasty. Restenosis by stimulation of vascular smooth muscle cells].
Bauriedel G
Fortschr Med; 1992 Apr; 110(11):196. PubMed ID: 1601359
[No Abstract] [Full Text] [Related]
2. [Recurrent stenosis following coronary angioplasty. Clinical, cell biological and molecular aspects].
Hombach V; Waltenberger J; Voisard R; Höher M
Z Kardiol; 1995 Jan; 84(1):5-21. PubMed ID: 7863714
[TBL] [Abstract][Full Text] [Related]
3. [Coronary circulation-derived plasma in patients with vascular restenosis stimulates the growth of coronary artery smooth muscle cells in culture].
Okamoto Y; Uemura S; Yamamoto H; Dohi K; Nakano H
Rinsho Byori; 1997 Oct; 45(10):1008-12. PubMed ID: 9369081
[TBL] [Abstract][Full Text] [Related]
4. [Restenosis after coronary angioplasty. Contribution of experimental models].
Bauters C; Hamon M; Van Belle E; Dupuis B; Lablanche JM; Bertrand ME
Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():47-56. PubMed ID: 8215780
[TBL] [Abstract][Full Text] [Related]
5. [Pathophysiology of restenosis following percutaneous transluminal coronary angioplasty].
Holm AM; Haunsø S; Hansen PR
Ugeskr Laeger; 1998 Feb; 160(9):1302-6. PubMed ID: 9495077
[TBL] [Abstract][Full Text] [Related]
6. [Restenosis after coronary angioplasty: its pathogenesis and prevention].
Marzocchi A; Marrozzini C; Piovaccari G; Fattori R; Castriota F; D'Anniballe G; Branzi A; Magnani B
Cardiologia; 1991 Dec; 36(12 Suppl 1):309-20. PubMed ID: 1841786
[TBL] [Abstract][Full Text] [Related]
7. [Pathophysiology and pathobiochemistry of restenosis].
Höfling B; Gonschior P; Nikol S; Bauriedel G; Welsch U; Nerlich A
Z Kardiol; 1994 May; 83(5):313-8. PubMed ID: 8053238
[TBL] [Abstract][Full Text] [Related]
8. The paradigm of restenosis following percutaneous transluminal coronary angioplasty.
Preisack MB; Karsch KR
Eur Heart J; 1993 Nov; 14 Suppl I():187-92. PubMed ID: 8293774
[TBL] [Abstract][Full Text] [Related]
9. [Restenosis after angioplasty. Clinical significance, pathobiology, future developments for suppression of recurrent stenoses].
Höfling B; Gonschior P; Esin S; Nikol S
Internist (Berl); 1997 Jan; 38(1):31-43. PubMed ID: 9119657
[No Abstract] [Full Text] [Related]
10. [Restenosis after percutaneous transluminal angioplasty: I. Etiology and clinical significance].
Alfke H; Böger RH; Bode-Böger SM
Vasa; 1996; 25(1):13-20. PubMed ID: 8851261
[TBL] [Abstract][Full Text] [Related]
11. Growth factors and vascular smooth muscle cell growth responses.
Delafontaine P
Eur Heart J; 1998 Jul; 19 Suppl G():G18-22. PubMed ID: 9717051
[TBL] [Abstract][Full Text] [Related]
12. [Pathological mechanisms of restenosis after angioplasty. Cell and molecular biology findings--possible new therapeutic approaches].
Bauriedel G
Fortschr Med; 1994 Aug; 112(24):322-3. PubMed ID: 7959499
[No Abstract] [Full Text] [Related]
13. [Biological determinants and prevention of coronary restenosis after angioplasty].
Chen BR; Zhu LY; Wang LH
Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Oct; 21(5):312-3. PubMed ID: 8200317
[No Abstract] [Full Text] [Related]
14. Regulation of smooth muscle cell proliferation and its possible role in preventing restenosis post-angioplasty.
Nikol S; Höfling B
Wien Klin Wochenschr; 1995; 107(13):379-89. PubMed ID: 7638968
[TBL] [Abstract][Full Text] [Related]
15. [Gene therapy for the treatment of restenosis after coronary angioplasty].
Rapacciuolo A; Indolfi C; Di Lorenzo E; Esposito G; Stabile E; Stingone AM; Avvedimento EV; Condorelli M; Chiariello M
Cardiologia; 1994 Dec; 39(12):843-7. PubMed ID: 7781002
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms and prevention of restenosis: from experimental models to clinical practice.
Bauters C; Meurice T; Hamon M; McFadden E; Lablanche JM; Bertrand ME
Cardiovasc Res; 1996 Jun; 31(6):835-46. PubMed ID: 8759238
[No Abstract] [Full Text] [Related]
17. Restenosis after percutaneous transluminal coronary angioplasty: new therapeutic insights from pathogenic mechanisms.
Berk BC; Harris K
Adv Intern Med; 1995; 40():445-501. PubMed ID: 7747655
[No Abstract] [Full Text] [Related]
18. Deposition of PG-M/versican is a major cause of human coronary restenosis after percutaneous transluminal coronary angioplasty.
Matsuura R; Isaka N; Imanaka-Yoshida K; Yoshida T; Sakakura T; Nakano T
J Pathol; 1996 Nov; 180(3):311-6. PubMed ID: 8958811
[TBL] [Abstract][Full Text] [Related]
19. Smooth muscle cell diversity and the extracellular matrix in a rat model of restenosis.
Majesky MW; Dong XR; Topouzis S
P R Health Sci J; 1996 Sep; 15(3):187-91. PubMed ID: 8994283
[TBL] [Abstract][Full Text] [Related]
20. [Vascular smooth muscle cells in coronary heart disease].
Tsukamoto T; Matsui T
Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):100-4. PubMed ID: 12436513
[No Abstract] [Full Text] [Related]
[Next] [New Search]
